NICE (UK National Institute for Clinical Excellence) approves bariatric surgery for morbid obesity
This article was originally published in Clinica
The UK National Institute for Clinical Excellence (NICE) has approved the use of bariatric surgery as a last-resort treatment for morbid obesity. People with a body mass index of 40kg/m(2), or 35kg/m(2) if presenting other significant diseases, will be eligible.
You may also be interested in...
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.
The biopharma sector is often accused of a being a slow-moving engine, but a look back over the last 20 years reveals that a lot has changed. In Vivo explores the history of high-impact M&A transactions in the industry between 1999 and 2019.